Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05980234 · ClinicalTrials.gov registry record
MDR - Longevity IT Oblique and Offset Liners
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 6
- Enrollment target
NCT05980234 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 6 participants.
The verdict
NCT05980234 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Longevity IT Oblique and Offset liners when used for primary or revision total hip arthroplasty (implants and instrumentation) at a minimum of 10-year follow-up.
Interventions
- DEVICE Total Hip Arthroplasty with Longevity IT Oblique Liners
- DEVICE Total Hip Arthroplasty with Longevity IT Offset Liners
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2024-11-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05980234
The ClinicalTrials.gov registry entry for NCT05980234 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Total Hip Arthroplasty with Longevity IT Oblique Liners is the first listed.
NCT05980234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05980234 about?
NCT05980234 is a clinical study titled "MDR - Longevity IT Oblique and Offset Liners". The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Longevity IT Oblique and Offset liners when used for primary or revision total hip arthroplasty (implants and instrumenta...
What is the current status of trial NCT05980234?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2023-08-30. Estimated completion is 2024-11-07.
What interventions are being tested in trial NCT05980234?
The interventions under investigation include: Total Hip Arthroplasty with Longevity IT Oblique Liners (DEVICE), Total Hip Arthroplasty with Longevity IT Offset Liners (DEVICE).
Who is sponsoring clinical trial NCT05980234?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.